The Trump administration nixed Compass Pathways’ inclusion on a list of ten candidates slated to receive a Commissioner’s National Priority Voucher (CNPV) last October, STAT reported earlier this week. As a reminder, CNPVs are intended to reduce the drug review timeline to just one or two months, the agency has said. According to STAT, the decision to block the voucher was made “just…
